首页> 外文期刊>Oral oncology >Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer
【24h】

Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer

机译:喉食管功能障碍自由存活和倾向评分匹配分析与器官保存和喉切切除术治疗咽癌

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: To assess the functional outcomes of patients treated for hypopharynx cancer and to obtain an unbiased estimate of survival difference between patients treated with chemoradiotherapy (CRT) or total laryngectomy (TL). Methods: Retrospective cohort study of all patients treated with curative intent for T1-T4 squamous cell carcinoma of the hypopharynx in The Netherlands Cancer Institute (1990-2013). Functional outcome following radiotherapy (RT) or CRT was measured using laryngo-esophageal dysfunction free survival rate (LDFS). Using propensity score (PS) matched analysis, we compared survival outcome of TL to CRT in T2-T4 patients. Results: We included 343 patients with T1T4 hypopharynx cancer. LDFS 2 and 5-years following CRT was respectively 44 and 32%. Following RT this was 39 and 30%. Patients were matched on the following variables: age, gender, TNM classification, subsite of tumor, decade of diagnosis, prior cancer, smoking, ACE27 score, BMI hemoglobin, albumin, and leukocyte level. With PS matching, we were able to match 26 TL patients with 26 CRT patients. The OS rates for TL and CRT in this matched cohort were respectively 56% and 46% at 5 years and 35% and 17% at 10 years. Conclusion: In conclusion, functional outcomes following RT or CRT are suboptimal and require improved treatment strategies or rehabilitation efforts. The OS results challenge the preposition that CRT and TLE are equivalent in terms of survival.
机译:目的:评估对白神癌症治疗的患者的功能结果,并在用化学疗法(CRT)或总喉部切除术(TL)治疗的患者之间的存活差异估计。方法:回顾性队列对荷兰癌症研究所的低温鳞状细胞癌治疗疗效治疗的所有患者(1990-2013)。使用喉对食管功能障碍自由存活率(LDFs)测量放疗后的功能结果(RT)或CRT。使用倾向评分(PS)匹配分析,我们将T1的生存结果与T2-T4患者的生存结果进行了比较。结果:我们包括343例T1T4后咽癌患者。 CRT后的LDFS 2和5年分别为44和32%。在RT之后,这是39和30%。患者在以下变量上匹配:年龄,性别,TNM分类,肿瘤子部分,诊断十年,癌症,吸烟,ACE27得分,BMI血红蛋白,白蛋白和白细胞水平。通过PS匹配,我们能够匹配26名TL患者26例CRT患者。此匹配队列中T1和CRT的OS率分别为56%和46%,5年,35%和17%,10年。结论:总之,RT或CRT后的功能结果是次优,需要改善治疗策略或康复工作。 OS结果挑战CRT和TLE在生存方面相当的介词。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号